Advanced Medical Diagnostics Group Ltd AMDG

1
Advanced Medical Diagnostics Group Ltd (AMDG)

• VariaCardio TF5
• The Future in Cardiac Screening

2
What is Heart Rate Variability (HRV)?

• HRV refers to the dynamic changes in heart rate
  and reflects the quality of cardiovascular
  autonomic control
• Quick identification of patients at risk
• Effective and reliable in population screening
• Method fully accepted by leading cardiologists
  and diabetologists
• Enables diagnostics of cardiac autonomic
  dysfunction

3
VariaCardio TF5 The Product

• Consists of a chest harness with integral ECG
  electrodes, microprocessor and telemetry unit,
  sophisticated software, data and security
  hardware, power supply, and carry case.

Receiver connects to
PC via serial cable.
4
VariaCardio TF5 The Product

• Measures the risk of a person developing
  heart-related disease
• Unique 15 minute test
• Complies to all known standards
• Medically proven method accepted by leading
  scientific medical organisations.

5
VariaCardio TF5 The Product

• HRV method fully accepted by leading
  cardiologists and diabetologists
• CE certified to the European Medical Device
  Directive ready for market
• FDA approval being sort to enable sales in the
  U.S
• 20 scientific papers 10 years research work
  proving system (5th generation model)
• Operating manuals complete
• Manufactured by MIE ISO9002 approved
• The TF5 is NOT A PROTOTYPE but a fully accepted
  and proven product

6
VariaCardio TF5 Key Features

• Standardised 15 minute test
• Safe, non-invasive, stress free examination
• Accurate, easily understood with reproducible
  results
• Wide spectrum of applications
• Advanced telemetric technology, complete data
  protection
• Remote analysis service available.

7
VariaCardio TF5 The Product

• Collects data, analyses results, providing
  real-time accurate HRV and high resolution
  full-time electrocardiogram over 15 minute test.

8
VariaCardio TF5 The Product

• Unique 3D graphics provides user friendly
  analysis compared to conventional statistical
  tables

9
VariaCardio TF5 The Evidence

• Patent application made
• VariaCardio TF5? Software ?
• 20 peer-reviewed medical papers
• Endorsed by UK/International leading
  cardiologists
• Currently used in several major international
  cardiology studies as part of proof of efficacy
  of new interventions
• HRV standards accepted and published by leading
  US/EU societies.

10
VariaCardio TF5 Priority Markets

• Hospitals
• Cardiologists for cardiac risk assessment
• Cardiac rehabilitation post MI
• Heart failure Hypertension management
• Endocrinologists for diabetics/neurologists
• Smoking clinics Weight loss clinics
• Psychiatrist for stress management

11
VariaCardio TF5 Priority Markets

• General Practitioners
• Health screening of at risk patients
• Health screening of cardiac and diabetic patients
• Stress management/palpitation investigation
• Chest pain evaluation
• Adjustment/monitoring of cardiovascular/diabetes
  medication

12
VariaCardio TF5 Priority Markets

• Private Practice
• In addition to the general practitioner market
• Health screening of worried well
• Insurance risk assessment
• Cardiac rehabilitation
• Sports medicine/training management

13
VariaCardio TF5 Priority Markets

• Pharmaceutical trials
• Estimated 7 million individuals throughout Europe
  are screened each year for drug trials.
• Each adverse event, risks withdrawal of the drug.
• Each day a trial is delayed costs an average 1m.
• Screening out unfit volunteers saves money and
  speeds up results.

14
VariaCardio TF5 Conclusions

• Unique device already proven itself the most
  advanced telemetric system for the accurate
  reliable measurement of cardiac dysfunction and
  cardiac risk.
• Clinical barriers removed preventing risk
  assessment to be performed, thus opening a
  completely new market.
• Cost effective device targeting cardiac
  dysfunction and cardiac risk.